nodes	percent_of_prediction	percent_of_DWPC	metapath
Timolol—ABCB1—melanoma	0.514	1	CbGaD
Timolol—CYP2D6—Vemurafenib—melanoma	0.0578	0.483	CbGbCtD
Timolol—ABCB1—Dactinomycin—melanoma	0.0408	0.341	CbGbCtD
Timolol—ABCB1—Docetaxel—melanoma	0.0211	0.176	CbGbCtD
Timolol—Blood pressure increased—Docetaxel—melanoma	0.00105	0.00395	CcSEcCtD
Timolol—Breast disorder—Temozolomide—melanoma	0.00103	0.0039	CcSEcCtD
Timolol—Hypotension—Vemurafenib—melanoma	0.00103	0.00388	CcSEcCtD
Timolol—Musculoskeletal discomfort—Vemurafenib—melanoma	0.001	0.00378	CcSEcCtD
Timolol—Decreased appetite—Vemurafenib—melanoma	0.000956	0.00361	CcSEcCtD
Timolol—Gastrointestinal disorder—Vemurafenib—melanoma	0.00095	0.00358	CcSEcCtD
Timolol—Fatigue—Vemurafenib—melanoma	0.000948	0.00358	CcSEcCtD
Timolol—Pulmonary oedema—Docetaxel—melanoma	0.000933	0.00352	CcSEcCtD
Timolol—Dysuria—Temozolomide—melanoma	0.000924	0.00349	CcSEcCtD
Timolol—Hyperglycaemia—Carmustine—melanoma	0.000923	0.00348	CcSEcCtD
Timolol—Upper respiratory tract infection—Temozolomide—melanoma	0.000919	0.00346	CcSEcCtD
Timolol—Erectile dysfunction—Temozolomide—melanoma	0.00091	0.00343	CcSEcCtD
Timolol—Depression—Carmustine—melanoma	0.000909	0.00343	CcSEcCtD
Timolol—Agranulocytosis—Dactinomycin—melanoma	0.000909	0.00343	CcSEcCtD
Timolol—Weight decreased—Temozolomide—melanoma	0.000894	0.00337	CcSEcCtD
Timolol—Hyperglycaemia—Temozolomide—melanoma	0.000892	0.00336	CcSEcCtD
Timolol—Depression—Temozolomide—melanoma	0.000879	0.00331	CcSEcCtD
Timolol—Body temperature increased—Vemurafenib—melanoma	0.00087	0.00328	CcSEcCtD
Timolol—Cardiac failure congestive—Docetaxel—melanoma	0.000839	0.00316	CcSEcCtD
Timolol—Alopecia—Bleomycin—melanoma	0.000829	0.00313	CcSEcCtD
Timolol—Sinusitis—Temozolomide—melanoma	0.000827	0.00312	CcSEcCtD
Timolol—Erythema—Bleomycin—melanoma	0.000817	0.00308	CcSEcCtD
Timolol—Hallucination—Carmustine—melanoma	0.000815	0.00307	CcSEcCtD
Timolol—Hypersensitivity—Vemurafenib—melanoma	0.00081	0.00306	CcSEcCtD
Timolol—Oedema peripheral—Carmustine—melanoma	0.000807	0.00304	CcSEcCtD
Timolol—Connective tissue disorder—Carmustine—melanoma	0.000805	0.00303	CcSEcCtD
Timolol—Visual disturbance—Docetaxel—melanoma	0.000803	0.00303	CcSEcCtD
Timolol—Asthenia—Vemurafenib—melanoma	0.000789	0.00298	CcSEcCtD
Timolol—Visual impairment—Carmustine—melanoma	0.000789	0.00298	CcSEcCtD
Timolol—Hallucination—Temozolomide—melanoma	0.000787	0.00297	CcSEcCtD
Timolol—Oedema peripheral—Temozolomide—melanoma	0.000779	0.00294	CcSEcCtD
Timolol—Cardiac failure—Docetaxel—melanoma	0.000779	0.00294	CcSEcCtD
Timolol—Pruritus—Vemurafenib—melanoma	0.000778	0.00293	CcSEcCtD
Timolol—Connective tissue disorder—Temozolomide—melanoma	0.000778	0.00293	CcSEcCtD
Timolol—Alopecia—Dactinomycin—melanoma	0.000773	0.00292	CcSEcCtD
Timolol—Eye disorder—Carmustine—melanoma	0.000765	0.00289	CcSEcCtD
Timolol—Visual impairment—Temozolomide—melanoma	0.000763	0.00288	CcSEcCtD
Timolol—Erythema—Dactinomycin—melanoma	0.000762	0.00287	CcSEcCtD
Timolol—Pain in extremity—Docetaxel—melanoma	0.000761	0.00287	CcSEcCtD
Timolol—Diarrhoea—Vemurafenib—melanoma	0.000753	0.00284	CcSEcCtD
Timolol—Eye disorder—Temozolomide—melanoma	0.000739	0.00279	CcSEcCtD
Timolol—Tinnitus—Temozolomide—melanoma	0.000738	0.00278	CcSEcCtD
Timolol—Cardiac disorder—Temozolomide—melanoma	0.000734	0.00277	CcSEcCtD
Timolol—Arrhythmia—Carmustine—melanoma	0.000731	0.00276	CcSEcCtD
Timolol—Dizziness—Vemurafenib—melanoma	0.000727	0.00274	CcSEcCtD
Timolol—Alopecia—Carmustine—melanoma	0.000724	0.00273	CcSEcCtD
Timolol—Angiopathy—Temozolomide—melanoma	0.000718	0.00271	CcSEcCtD
Timolol—Mental disorder—Carmustine—melanoma	0.000717	0.00271	CcSEcCtD
Timolol—Immune system disorder—Temozolomide—melanoma	0.000715	0.0027	CcSEcCtD
Timolol—Mediastinal disorder—Temozolomide—melanoma	0.000713	0.00269	CcSEcCtD
Timolol—Malnutrition—Carmustine—melanoma	0.000713	0.00269	CcSEcCtD
Timolol—Erythema—Carmustine—melanoma	0.000713	0.00269	CcSEcCtD
Timolol—Cough—Bleomycin—melanoma	0.000713	0.00269	CcSEcCtD
Timolol—Liver function test abnormal—Docetaxel—melanoma	0.000702	0.00265	CcSEcCtD
Timolol—Vomiting—Vemurafenib—melanoma	0.000699	0.00264	CcSEcCtD
Timolol—Alopecia—Temozolomide—melanoma	0.000699	0.00264	CcSEcCtD
Timolol—Chest pain—Bleomycin—melanoma	0.000695	0.00262	CcSEcCtD
Timolol—Myalgia—Bleomycin—melanoma	0.000695	0.00262	CcSEcCtD
Timolol—Abdominal pain upper—Docetaxel—melanoma	0.000695	0.00262	CcSEcCtD
Timolol—Rash—Vemurafenib—melanoma	0.000694	0.00262	CcSEcCtD
Timolol—Mental disorder—Temozolomide—melanoma	0.000693	0.00261	CcSEcCtD
Timolol—Dermatitis—Vemurafenib—melanoma	0.000693	0.00261	CcSEcCtD
Timolol—Headache—Vemurafenib—melanoma	0.000689	0.0026	CcSEcCtD
Timolol—Erythema—Temozolomide—melanoma	0.000689	0.0026	CcSEcCtD
Timolol—Malnutrition—Temozolomide—melanoma	0.000689	0.0026	CcSEcCtD
Timolol—Breast disorder—Docetaxel—melanoma	0.000687	0.00259	CcSEcCtD
Timolol—Discomfort—Bleomycin—melanoma	0.000687	0.00259	CcSEcCtD
Timolol—Nasopharyngitis—Docetaxel—melanoma	0.00068	0.00257	CcSEcCtD
Timolol—Dysgeusia—Temozolomide—melanoma	0.000675	0.00254	CcSEcCtD
Timolol—Confusional state—Bleomycin—melanoma	0.000672	0.00253	CcSEcCtD
Timolol—Vision blurred—Carmustine—melanoma	0.000672	0.00253	CcSEcCtD
Timolol—Anaphylactic shock—Bleomycin—melanoma	0.000666	0.00251	CcSEcCtD
Timolol—Oedema—Bleomycin—melanoma	0.000666	0.00251	CcSEcCtD
Timolol—Infection—Bleomycin—melanoma	0.000662	0.0025	CcSEcCtD
Timolol—Nausea—Vemurafenib—melanoma	0.000653	0.00246	CcSEcCtD
Timolol—Vision blurred—Temozolomide—melanoma	0.000649	0.00245	CcSEcCtD
Timolol—Myalgia—Dactinomycin—melanoma	0.000648	0.00245	CcSEcCtD
Timolol—Bronchospasm—Docetaxel—melanoma	0.000647	0.00244	CcSEcCtD
Timolol—Discomfort—Dactinomycin—melanoma	0.000641	0.00242	CcSEcCtD
Timolol—Angina pectoris—Docetaxel—melanoma	0.00064	0.00242	CcSEcCtD
Timolol—Anorexia—Bleomycin—melanoma	0.000635	0.0024	CcSEcCtD
Timolol—Angioedema—Temozolomide—melanoma	0.000629	0.00237	CcSEcCtD
Timolol—Hypotension—Bleomycin—melanoma	0.000623	0.00235	CcSEcCtD
Timolol—Oedema—Dactinomycin—melanoma	0.000622	0.00234	CcSEcCtD
Timolol—Vertigo—Temozolomide—melanoma	0.000619	0.00233	CcSEcCtD
Timolol—Infection—Dactinomycin—melanoma	0.000617	0.00233	CcSEcCtD
Timolol—Hypertension—Carmustine—melanoma	0.000615	0.00232	CcSEcCtD
Timolol—Palpitations—Temozolomide—melanoma	0.000609	0.0023	CcSEcCtD
Timolol—Musculoskeletal discomfort—Bleomycin—melanoma	0.000607	0.00229	CcSEcCtD
Timolol—Chest pain—Carmustine—melanoma	0.000607	0.00229	CcSEcCtD
Timolol—Myalgia—Carmustine—melanoma	0.000607	0.00229	CcSEcCtD
Timolol—Anxiety—Carmustine—melanoma	0.000605	0.00228	CcSEcCtD
Timolol—Cough—Temozolomide—melanoma	0.000601	0.00227	CcSEcCtD
Timolol—Paraesthesia—Bleomycin—melanoma	0.000598	0.00226	CcSEcCtD
Timolol—Weight decreased—Docetaxel—melanoma	0.000595	0.00224	CcSEcCtD
Timolol—Hypertension—Temozolomide—melanoma	0.000595	0.00224	CcSEcCtD
Timolol—Dyspnoea—Bleomycin—melanoma	0.000594	0.00224	CcSEcCtD
Timolol—Anorexia—Dactinomycin—melanoma	0.000592	0.00223	CcSEcCtD
Timolol—Confusional state—Carmustine—melanoma	0.000587	0.00221	CcSEcCtD
Timolol—Myalgia—Temozolomide—melanoma	0.000586	0.00221	CcSEcCtD
Timolol—Arthralgia—Temozolomide—melanoma	0.000586	0.00221	CcSEcCtD
Timolol—Anxiety—Temozolomide—melanoma	0.000584	0.0022	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000582	0.0022	CcSEcCtD
Timolol—Oedema—Carmustine—melanoma	0.000582	0.00219	CcSEcCtD
Timolol—Discomfort—Temozolomide—melanoma	0.000579	0.00219	CcSEcCtD
Timolol—Decreased appetite—Bleomycin—melanoma	0.000579	0.00218	CcSEcCtD
Timolol—Infection—Carmustine—melanoma	0.000578	0.00218	CcSEcCtD
Timolol—Dry mouth—Temozolomide—melanoma	0.000574	0.00216	CcSEcCtD
Timolol—Pain—Bleomycin—melanoma	0.00057	0.00215	CcSEcCtD
Timolol—Conjunctivitis—Docetaxel—melanoma	0.00057	0.00215	CcSEcCtD
Timolol—Confusional state—Temozolomide—melanoma	0.000567	0.00214	CcSEcCtD
Timolol—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000566	0.00214	CcSEcCtD
Timolol—Oedema—Temozolomide—melanoma	0.000562	0.00212	CcSEcCtD
Timolol—Anaphylactic shock—Temozolomide—melanoma	0.000562	0.00212	CcSEcCtD
Timolol—Infection—Temozolomide—melanoma	0.000558	0.00211	CcSEcCtD
Timolol—Anorexia—Carmustine—melanoma	0.000554	0.00209	CcSEcCtD
Timolol—Epistaxis—Docetaxel—melanoma	0.000553	0.00209	CcSEcCtD
Timolol—Nervous system disorder—Temozolomide—melanoma	0.000551	0.00208	CcSEcCtD
Timolol—Feeling abnormal—Bleomycin—melanoma	0.000549	0.00207	CcSEcCtD
Timolol—Agranulocytosis—Docetaxel—melanoma	0.000547	0.00206	CcSEcCtD
Timolol—Skin disorder—Temozolomide—melanoma	0.000546	0.00206	CcSEcCtD
Timolol—Hypotension—Carmustine—melanoma	0.000544	0.00205	CcSEcCtD
Timolol—Hyperhidrosis—Temozolomide—melanoma	0.000543	0.00205	CcSEcCtD
Timolol—Decreased appetite—Dactinomycin—melanoma	0.00054	0.00204	CcSEcCtD
Timolol—Fatigue—Dactinomycin—melanoma	0.000536	0.00202	CcSEcCtD
Timolol—Anorexia—Temozolomide—melanoma	0.000536	0.00202	CcSEcCtD
Timolol—Pain—Dactinomycin—melanoma	0.000531	0.002	CcSEcCtD
Timolol—Musculoskeletal discomfort—Carmustine—melanoma	0.00053	0.002	CcSEcCtD
Timolol—Urticaria—Bleomycin—melanoma	0.000529	0.002	CcSEcCtD
Timolol—Rhinitis—Docetaxel—melanoma	0.000528	0.00199	CcSEcCtD
Timolol—Body temperature increased—Bleomycin—melanoma	0.000527	0.00199	CcSEcCtD
Timolol—Insomnia—Carmustine—melanoma	0.000526	0.00198	CcSEcCtD
Timolol—Paraesthesia—Carmustine—melanoma	0.000522	0.00197	CcSEcCtD
Timolol—Dyspnoea—Carmustine—melanoma	0.000519	0.00196	CcSEcCtD
Timolol—Oedema peripheral—Docetaxel—melanoma	0.000518	0.00195	CcSEcCtD
Timolol—Somnolence—Carmustine—melanoma	0.000517	0.00195	CcSEcCtD
Timolol—Connective tissue disorder—Docetaxel—melanoma	0.000517	0.00195	CcSEcCtD
Timolol—Feeling abnormal—Dactinomycin—melanoma	0.000512	0.00193	CcSEcCtD
Timolol—Musculoskeletal discomfort—Temozolomide—melanoma	0.000512	0.00193	CcSEcCtD
Timolol—Insomnia—Temozolomide—melanoma	0.000508	0.00192	CcSEcCtD
Timolol—Gastrointestinal pain—Dactinomycin—melanoma	0.000508	0.00192	CcSEcCtD
Timolol—Visual impairment—Docetaxel—melanoma	0.000507	0.00191	CcSEcCtD
Timolol—Decreased appetite—Carmustine—melanoma	0.000506	0.00191	CcSEcCtD
Timolol—Paraesthesia—Temozolomide—melanoma	0.000505	0.0019	CcSEcCtD
Timolol—Gastrointestinal disorder—Carmustine—melanoma	0.000502	0.00189	CcSEcCtD
Timolol—Dyspnoea—Temozolomide—melanoma	0.000501	0.00189	CcSEcCtD
Timolol—Somnolence—Temozolomide—melanoma	0.0005	0.00188	CcSEcCtD
Timolol—Pain—Carmustine—melanoma	0.000497	0.00188	CcSEcCtD
Timolol—Dyspepsia—Temozolomide—melanoma	0.000495	0.00187	CcSEcCtD
Timolol—Eye disorder—Docetaxel—melanoma	0.000492	0.00185	CcSEcCtD
Timolol—Body temperature increased—Dactinomycin—melanoma	0.000491	0.00185	CcSEcCtD
Timolol—Abdominal pain—Dactinomycin—melanoma	0.000491	0.00185	CcSEcCtD
Timolol—Hypersensitivity—Bleomycin—melanoma	0.000491	0.00185	CcSEcCtD
Timolol—Decreased appetite—Temozolomide—melanoma	0.000489	0.00184	CcSEcCtD
Timolol—Cardiac disorder—Docetaxel—melanoma	0.000488	0.00184	CcSEcCtD
Timolol—Gastrointestinal disorder—Temozolomide—melanoma	0.000485	0.00183	CcSEcCtD
Timolol—Fatigue—Temozolomide—melanoma	0.000485	0.00183	CcSEcCtD
Timolol—Pain—Temozolomide—melanoma	0.000481	0.00181	CcSEcCtD
Timolol—Feeling abnormal—Carmustine—melanoma	0.000479	0.00181	CcSEcCtD
Timolol—Asthenia—Bleomycin—melanoma	0.000478	0.0018	CcSEcCtD
Timolol—Angiopathy—Docetaxel—melanoma	0.000477	0.0018	CcSEcCtD
Timolol—Gastrointestinal pain—Carmustine—melanoma	0.000476	0.00179	CcSEcCtD
Timolol—Immune system disorder—Docetaxel—melanoma	0.000475	0.00179	CcSEcCtD
Timolol—Mediastinal disorder—Docetaxel—melanoma	0.000474	0.00179	CcSEcCtD
Timolol—Pruritus—Bleomycin—melanoma	0.000471	0.00178	CcSEcCtD
Timolol—Arrhythmia—Docetaxel—melanoma	0.00047	0.00177	CcSEcCtD
Timolol—Alopecia—Docetaxel—melanoma	0.000465	0.00175	CcSEcCtD
Timolol—Feeling abnormal—Temozolomide—melanoma	0.000463	0.00175	CcSEcCtD
Timolol—Mental disorder—Docetaxel—melanoma	0.000461	0.00174	CcSEcCtD
Timolol—Body temperature increased—Carmustine—melanoma	0.00046	0.00173	CcSEcCtD
Timolol—Abdominal pain—Carmustine—melanoma	0.00046	0.00173	CcSEcCtD
Timolol—Gastrointestinal pain—Temozolomide—melanoma	0.00046	0.00173	CcSEcCtD
Timolol—Malnutrition—Docetaxel—melanoma	0.000458	0.00173	CcSEcCtD
Timolol—Erythema—Docetaxel—melanoma	0.000458	0.00173	CcSEcCtD
Timolol—Hypersensitivity—Dactinomycin—melanoma	0.000458	0.00173	CcSEcCtD
Timolol—Dysgeusia—Docetaxel—melanoma	0.000449	0.00169	CcSEcCtD
Timolol—Urticaria—Temozolomide—melanoma	0.000447	0.00168	CcSEcCtD
Timolol—Asthenia—Dactinomycin—melanoma	0.000446	0.00168	CcSEcCtD
Timolol—Abdominal pain—Temozolomide—melanoma	0.000444	0.00168	CcSEcCtD
Timolol—Body temperature increased—Temozolomide—melanoma	0.000444	0.00168	CcSEcCtD
Timolol—Hypersensitivity—Carmustine—melanoma	0.000429	0.00162	CcSEcCtD
Timolol—Diarrhoea—Dactinomycin—melanoma	0.000425	0.0016	CcSEcCtD
Timolol—Vomiting—Bleomycin—melanoma	0.000424	0.0016	CcSEcCtD
Timolol—Rash—Bleomycin—melanoma	0.00042	0.00158	CcSEcCtD
Timolol—Dermatitis—Bleomycin—melanoma	0.00042	0.00158	CcSEcCtD
Timolol—Asthenia—Carmustine—melanoma	0.000417	0.00157	CcSEcCtD
Timolol—Hypersensitivity—Temozolomide—melanoma	0.000414	0.00156	CcSEcCtD
Timolol—Syncope—Docetaxel—melanoma	0.000411	0.00155	CcSEcCtD
Timolol—Palpitations—Docetaxel—melanoma	0.000405	0.00153	CcSEcCtD
Timolol—Asthenia—Temozolomide—melanoma	0.000403	0.00152	CcSEcCtD
Timolol—Loss of consciousness—Docetaxel—melanoma	0.000403	0.00152	CcSEcCtD
Timolol—Cough—Docetaxel—melanoma	0.0004	0.00151	CcSEcCtD
Timolol—Diarrhoea—Carmustine—melanoma	0.000398	0.0015	CcSEcCtD
Timolol—Pruritus—Temozolomide—melanoma	0.000398	0.0015	CcSEcCtD
Timolol—Nausea—Bleomycin—melanoma	0.000396	0.00149	CcSEcCtD
Timolol—Hypertension—Docetaxel—melanoma	0.000395	0.00149	CcSEcCtD
Timolol—Vomiting—Dactinomycin—melanoma	0.000395	0.00149	CcSEcCtD
Timolol—Rash—Dactinomycin—melanoma	0.000392	0.00148	CcSEcCtD
Timolol—Arthralgia—Docetaxel—melanoma	0.00039	0.00147	CcSEcCtD
Timolol—Chest pain—Docetaxel—melanoma	0.00039	0.00147	CcSEcCtD
Timolol—Myalgia—Docetaxel—melanoma	0.00039	0.00147	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000387	0.00146	CcSEcCtD
Timolol—Dizziness—Carmustine—melanoma	0.000385	0.00145	CcSEcCtD
Timolol—Diarrhoea—Temozolomide—melanoma	0.000385	0.00145	CcSEcCtD
Timolol—Dry mouth—Docetaxel—melanoma	0.000381	0.00144	CcSEcCtD
Timolol—Confusional state—Docetaxel—melanoma	0.000377	0.00142	CcSEcCtD
Timolol—Anaphylactic shock—Docetaxel—melanoma	0.000374	0.00141	CcSEcCtD
Timolol—Oedema—Docetaxel—melanoma	0.000374	0.00141	CcSEcCtD
Timolol—Dizziness—Temozolomide—melanoma	0.000372	0.0014	CcSEcCtD
Timolol—Infection—Docetaxel—melanoma	0.000371	0.0014	CcSEcCtD
Timolol—Vomiting—Carmustine—melanoma	0.00037	0.00139	CcSEcCtD
Timolol—Nausea—Dactinomycin—melanoma	0.000369	0.00139	CcSEcCtD
Timolol—Shock—Docetaxel—melanoma	0.000368	0.00139	CcSEcCtD
Timolol—Rash—Carmustine—melanoma	0.000367	0.00138	CcSEcCtD
Timolol—Nervous system disorder—Docetaxel—melanoma	0.000367	0.00138	CcSEcCtD
Timolol—Dermatitis—Carmustine—melanoma	0.000366	0.00138	CcSEcCtD
Timolol—Headache—Carmustine—melanoma	0.000364	0.00137	CcSEcCtD
Timolol—Skin disorder—Docetaxel—melanoma	0.000363	0.00137	CcSEcCtD
Timolol—Vomiting—Temozolomide—melanoma	0.000357	0.00135	CcSEcCtD
Timolol—Anorexia—Docetaxel—melanoma	0.000356	0.00134	CcSEcCtD
Timolol—Rash—Temozolomide—melanoma	0.000354	0.00134	CcSEcCtD
Timolol—Dermatitis—Temozolomide—melanoma	0.000354	0.00134	CcSEcCtD
Timolol—Headache—Temozolomide—melanoma	0.000352	0.00133	CcSEcCtD
Timolol—Hypotension—Docetaxel—melanoma	0.000349	0.00132	CcSEcCtD
Timolol—Nausea—Carmustine—melanoma	0.000346	0.0013	CcSEcCtD
Timolol—Musculoskeletal discomfort—Docetaxel—melanoma	0.000341	0.00128	CcSEcCtD
Timolol—Insomnia—Docetaxel—melanoma	0.000338	0.00128	CcSEcCtD
Timolol—Paraesthesia—Docetaxel—melanoma	0.000336	0.00127	CcSEcCtD
Timolol—Nausea—Temozolomide—melanoma	0.000334	0.00126	CcSEcCtD
Timolol—Dyspnoea—Docetaxel—melanoma	0.000333	0.00126	CcSEcCtD
Timolol—Somnolence—Docetaxel—melanoma	0.000332	0.00125	CcSEcCtD
Timolol—Dyspepsia—Docetaxel—melanoma	0.000329	0.00124	CcSEcCtD
Timolol—Decreased appetite—Docetaxel—melanoma	0.000325	0.00123	CcSEcCtD
Timolol—Gastrointestinal disorder—Docetaxel—melanoma	0.000323	0.00122	CcSEcCtD
Timolol—Fatigue—Docetaxel—melanoma	0.000322	0.00122	CcSEcCtD
Timolol—Pain—Docetaxel—melanoma	0.00032	0.00121	CcSEcCtD
Timolol—Feeling abnormal—Docetaxel—melanoma	0.000308	0.00116	CcSEcCtD
Timolol—Gastrointestinal pain—Docetaxel—melanoma	0.000306	0.00115	CcSEcCtD
Timolol—Body temperature increased—Docetaxel—melanoma	0.000296	0.00111	CcSEcCtD
Timolol—Abdominal pain—Docetaxel—melanoma	0.000296	0.00111	CcSEcCtD
Timolol—Hypersensitivity—Docetaxel—melanoma	0.000275	0.00104	CcSEcCtD
Timolol—Asthenia—Docetaxel—melanoma	0.000268	0.00101	CcSEcCtD
Timolol—Pruritus—Docetaxel—melanoma	0.000264	0.000997	CcSEcCtD
Timolol—Diarrhoea—Docetaxel—melanoma	0.000256	0.000965	CcSEcCtD
Timolol—Dizziness—Docetaxel—melanoma	0.000247	0.000932	CcSEcCtD
Timolol—Vomiting—Docetaxel—melanoma	0.000238	0.000896	CcSEcCtD
Timolol—Rash—Docetaxel—melanoma	0.000236	0.000889	CcSEcCtD
Timolol—Dermatitis—Docetaxel—melanoma	0.000235	0.000888	CcSEcCtD
Timolol—Headache—Docetaxel—melanoma	0.000234	0.000883	CcSEcCtD
Timolol—Nausea—Docetaxel—melanoma	0.000222	0.000837	CcSEcCtD
Timolol—ADRB1—Signaling by GPCR—PIK3CD—melanoma	2.48e-05	0.000246	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PIK3CD—melanoma	2.47e-05	0.000245	CbGpPWpGaD
Timolol—ABCB1—Metabolism—VCAN—melanoma	2.46e-05	0.000244	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—SOCS1—melanoma	2.45e-05	0.000243	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—PIK3CA—melanoma	2.45e-05	0.000243	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—MAP2K1—melanoma	2.44e-05	0.000243	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—S100B—melanoma	2.44e-05	0.000243	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—PIK3CD—melanoma	2.43e-05	0.000241	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—KRAS—melanoma	2.42e-05	0.00024	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—ERBB4—melanoma	2.39e-05	0.000237	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.39e-05	0.000237	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—PIK3CB—melanoma	2.38e-05	0.000237	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CDKN2B—melanoma	2.37e-05	0.000235	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—FGF2—melanoma	2.37e-05	0.000235	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—ERBB4—melanoma	2.34e-05	0.000232	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—PIK3CB—melanoma	2.33e-05	0.000231	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—VCAN—melanoma	2.32e-05	0.00023	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CDKN2B—melanoma	2.32e-05	0.00023	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.3e-05	0.000229	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CD86—melanoma	2.29e-05	0.000227	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—CXCL8—melanoma	2.29e-05	0.000227	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—EDN1—melanoma	2.27e-05	0.000226	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CD86—melanoma	2.24e-05	0.000223	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—CXCL8—melanoma	2.24e-05	0.000222	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—EDN1—melanoma	2.22e-05	0.000221	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—PIK3CA—melanoma	2.22e-05	0.000221	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—FGF1—melanoma	2.22e-05	0.000221	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CSF2—melanoma	2.22e-05	0.000221	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MDM2—melanoma	2.21e-05	0.00022	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—IL2—melanoma	2.19e-05	0.000217	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—ERBB2—melanoma	2.18e-05	0.000217	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—E2F1—melanoma	2.17e-05	0.000216	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CSF2—melanoma	2.17e-05	0.000216	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—FGF1—melanoma	2.17e-05	0.000216	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—PIK3CB—melanoma	2.16e-05	0.000215	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PIK3CB—melanoma	2.15e-05	0.000214	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PDGFRA—melanoma	2.15e-05	0.000214	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—IL2—melanoma	2.14e-05	0.000213	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—ITGB3—melanoma	2.13e-05	0.000211	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PRKCA—melanoma	2.13e-05	0.000211	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	2.13e-05	0.000211	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP17A1—melanoma	2.13e-05	0.000211	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—E2F1—melanoma	2.13e-05	0.000211	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—PIK3CB—melanoma	2.12e-05	0.00021	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PDGFRA—melanoma	2.1e-05	0.000209	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.1e-05	0.000208	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—SPP1—melanoma	2.09e-05	0.000207	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—ITGB3—melanoma	2.08e-05	0.000207	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PRKCA—melanoma	2.08e-05	0.000207	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MAP2K2—melanoma	2.08e-05	0.000207	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—CXCL8—melanoma	2.08e-05	0.000206	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP17A1—melanoma	2.08e-05	0.000206	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	2.07e-05	0.000206	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CXCL8—melanoma	2.07e-05	0.000205	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—HRAS—melanoma	2.06e-05	0.000204	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—SPP1—melanoma	2.04e-05	0.000203	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MAP2K2—melanoma	2.04e-05	0.000202	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—CXCL8—melanoma	2.03e-05	0.000202	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CDKN1B—melanoma	2.02e-05	0.000201	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GNA11—melanoma	2.01e-05	0.000199	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—AKT1—melanoma	2e-05	0.000199	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—IL2—melanoma	1.99e-05	0.000197	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CASP3—melanoma	1.98e-05	0.000197	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TERT—melanoma	1.98e-05	0.000197	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—IL2—melanoma	1.98e-05	0.000196	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—RAC1—melanoma	1.97e-05	0.000196	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—IL6—melanoma	1.97e-05	0.000195	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—FASN—melanoma	1.97e-05	0.000195	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GNA11—melanoma	1.96e-05	0.000195	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP17A1—melanoma	1.96e-05	0.000194	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—IL2—melanoma	1.94e-05	0.000193	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TERT—melanoma	1.94e-05	0.000192	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—SLC5A5—melanoma	1.93e-05	0.000192	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—RAC1—melanoma	1.93e-05	0.000192	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CCND1—melanoma	1.93e-05	0.000191	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	1.92e-05	0.000191	CbGpPWpGaD
Timolol—ABCB1—Metabolism—FASN—melanoma	1.92e-05	0.00019	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CTNNB1—melanoma	1.91e-05	0.00019	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—HIF1A—melanoma	1.89e-05	0.000188	CbGpPWpGaD
Timolol—ABCB1—Metabolism—SLC5A5—melanoma	1.89e-05	0.000187	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MMP9—melanoma	1.87e-05	0.000186	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CD44—melanoma	1.87e-05	0.000185	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GNAQ—melanoma	1.87e-05	0.000185	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CDKN1A—melanoma	1.87e-05	0.000185	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PTEN—melanoma	1.86e-05	0.000185	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—HIF1A—melanoma	1.85e-05	0.000184	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—NFKB1—melanoma	1.85e-05	0.000184	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GNA11—melanoma	1.85e-05	0.000183	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.83e-05	0.000182	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GNAQ—melanoma	1.82e-05	0.000181	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CD44—melanoma	1.82e-05	0.000181	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—AKT1—melanoma	1.82e-05	0.00018	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.81e-05	0.00018	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—KDR—melanoma	1.81e-05	0.00018	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—FASN—melanoma	1.81e-05	0.000179	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP1B1—melanoma	1.79e-05	0.000178	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—SLC5A5—melanoma	1.78e-05	0.000177	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—KDR—melanoma	1.77e-05	0.000176	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP1B1—melanoma	1.75e-05	0.000173	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—FN1—melanoma	1.74e-05	0.000173	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GNAQ—melanoma	1.72e-05	0.000171	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CD44—melanoma	1.72e-05	0.000171	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NOTCH1—melanoma	1.71e-05	0.000169	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—FN1—melanoma	1.71e-05	0.000169	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—VEGFA—melanoma	1.68e-05	0.000167	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CD80—melanoma	1.67e-05	0.000166	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NOTCH1—melanoma	1.67e-05	0.000166	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—KIT—melanoma	1.67e-05	0.000166	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3CG—melanoma	1.67e-05	0.000166	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—APC—melanoma	1.67e-05	0.000166	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—NRAS—melanoma	1.67e-05	0.000166	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—STAT3—melanoma	1.66e-05	0.000165	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—NRAS—melanoma	1.66e-05	0.000165	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—EGF—melanoma	1.65e-05	0.000164	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP1B1—melanoma	1.65e-05	0.000163	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CD80—melanoma	1.63e-05	0.000162	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3CG—melanoma	1.63e-05	0.000162	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—KIT—melanoma	1.63e-05	0.000162	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—APC—melanoma	1.63e-05	0.000162	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—NRAS—melanoma	1.63e-05	0.000162	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—EGF—melanoma	1.61e-05	0.00016	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—MAPK3—melanoma	1.6e-05	0.000159	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MAPK3—melanoma	1.59e-05	0.000158	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.58e-05	0.000157	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—BRAF—melanoma	1.57e-05	0.000156	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—MAPK3—melanoma	1.56e-05	0.000155	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MYC—melanoma	1.55e-05	0.000154	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—BRAF—melanoma	1.53e-05	0.000152	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IGF1—melanoma	1.53e-05	0.000152	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—MAPK1—melanoma	1.52e-05	0.000151	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—EGFR—melanoma	1.52e-05	0.000151	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MAPK1—melanoma	1.51e-05	0.00015	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—EGFR—melanoma	1.51e-05	0.00015	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IGF1—melanoma	1.49e-05	0.000148	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—MAPK1—melanoma	1.49e-05	0.000148	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—EGFR—melanoma	1.49e-05	0.000148	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MAP2K1—melanoma	1.48e-05	0.000147	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ABCB1—melanoma	1.47e-05	0.000146	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3CD—melanoma	1.47e-05	0.000146	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—PIK3CA—melanoma	1.45e-05	0.000144	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MAP2K1—melanoma	1.44e-05	0.000143	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—KRAS—melanoma	1.44e-05	0.000143	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3CD—melanoma	1.43e-05	0.000142	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—KRAS—melanoma	1.43e-05	0.000142	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—PIK3CA—melanoma	1.42e-05	0.000141	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—KRAS—melanoma	1.4e-05	0.000139	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—FGF2—melanoma	1.4e-05	0.000139	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—FGF2—melanoma	1.37e-05	0.000136	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PRKCA—melanoma	1.36e-05	0.000135	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ABCB1—melanoma	1.36e-05	0.000135	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ERCC2—melanoma	1.35e-05	0.000134	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PRKCA—melanoma	1.32e-05	0.000131	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—PIK3CA—melanoma	1.32e-05	0.000131	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MDM2—melanoma	1.31e-05	0.00013	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ERCC2—melanoma	1.31e-05	0.00013	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PIK3CA—melanoma	1.31e-05	0.00013	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—ERBB2—melanoma	1.3e-05	0.000129	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—PIK3CA—melanoma	1.29e-05	0.000128	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MDM2—melanoma	1.29e-05	0.000128	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3CB—melanoma	1.28e-05	0.000127	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—TP53—melanoma	1.27e-05	0.000126	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—ERBB2—melanoma	1.27e-05	0.000126	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3CB—melanoma	1.25e-05	0.000124	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PRKCA—melanoma	1.25e-05	0.000124	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ERCC2—melanoma	1.24e-05	0.000123	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CXCL8—melanoma	1.23e-05	0.000122	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—HRAS—melanoma	1.22e-05	0.000121	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—HRAS—melanoma	1.21e-05	0.000121	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CXCL8—melanoma	1.2e-05	0.000119	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CDKN1B—melanoma	1.2e-05	0.000119	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—HRAS—melanoma	1.19e-05	0.000119	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—AKT1—melanoma	1.19e-05	0.000118	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CASP3—melanoma	1.18e-05	0.000117	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IL2—melanoma	1.17e-05	0.000117	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CDKN1B—melanoma	1.17e-05	0.000117	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—IL6—melanoma	1.17e-05	0.000116	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—IL6—melanoma	1.16e-05	0.000115	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—AKT1—melanoma	1.16e-05	0.000115	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CASP3—melanoma	1.15e-05	0.000114	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IL2—melanoma	1.15e-05	0.000114	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CCND1—melanoma	1.14e-05	0.000114	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—IL6—melanoma	1.14e-05	0.000113	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CTNNB1—melanoma	1.13e-05	0.000113	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CCND1—melanoma	1.12e-05	0.000111	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.11e-05	0.000111	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MMP9—melanoma	1.11e-05	0.00011	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CTNNB1—melanoma	1.11e-05	0.00011	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CDKN1A—melanoma	1.11e-05	0.00011	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PTEN—melanoma	1.1e-05	0.00011	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NFKB1—melanoma	1.1e-05	0.000109	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MMP9—melanoma	1.09e-05	0.000108	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CDKN1A—melanoma	1.08e-05	0.000108	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PTEN—melanoma	1.08e-05	0.000107	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—AKT1—melanoma	1.08e-05	0.000107	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NFKB1—melanoma	1.08e-05	0.000107	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—AKT1—melanoma	1.07e-05	0.000106	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3CG—melanoma	1.06e-05	0.000106	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—AKT1—melanoma	1.05e-05	0.000105	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3CG—melanoma	1.04e-05	0.000103	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PPARG—melanoma	1.03e-05	0.000102	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PPARG—melanoma	1e-05	9.94e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—VEGFA—melanoma	9.98e-06	9.91e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—STAT3—melanoma	9.88e-06	9.81e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NRAS—melanoma	9.86e-06	9.78e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3CG—melanoma	9.77e-06	9.7e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—VEGFA—melanoma	9.76e-06	9.69e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—STAT3—melanoma	9.66e-06	9.6e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NRAS—melanoma	9.64e-06	9.57e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MAPK3—melanoma	9.44e-06	9.37e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PPARG—melanoma	9.43e-06	9.37e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3CD—melanoma	9.34e-06	9.28e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MAPK3—melanoma	9.23e-06	9.17e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ALB—melanoma	9.22e-06	9.16e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MYC—melanoma	9.18e-06	9.11e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3CD—melanoma	9.12e-06	9.05e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ALB—melanoma	9e-06	8.94e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MAPK1—melanoma	8.98e-06	8.92e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MYC—melanoma	8.98e-06	8.92e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—EGFR—melanoma	8.98e-06	8.91e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MAPK1—melanoma	8.78e-06	8.72e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—EGFR—melanoma	8.78e-06	8.72e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3CD—melanoma	8.59e-06	8.53e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—KRAS—melanoma	8.48e-06	8.42e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ALB—melanoma	8.48e-06	8.42e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—KRAS—melanoma	8.3e-06	8.24e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3CB—melanoma	8.14e-06	8.08e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PTGS2—melanoma	8.07e-06	8.01e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3CB—melanoma	7.95e-06	7.89e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PTGS2—melanoma	7.87e-06	7.82e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3CA—melanoma	7.79e-06	7.74e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3CA—melanoma	7.62e-06	7.57e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TP53—melanoma	7.54e-06	7.49e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3CB—melanoma	7.49e-06	7.44e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PTGS2—melanoma	7.42e-06	7.37e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TP53—melanoma	7.37e-06	7.32e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—HRAS—melanoma	7.21e-06	7.16e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—HRAS—melanoma	7.05e-06	7e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PTEN—melanoma	7.04e-06	6.99e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IL6—melanoma	6.9e-06	6.85e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PTEN—melanoma	6.87e-06	6.82e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IL6—melanoma	6.75e-06	6.7e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PTEN—melanoma	6.47e-06	6.43e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—AKT1—melanoma	6.37e-06	6.32e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—AKT1—melanoma	6.23e-06	6.18e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3CA—melanoma	4.96e-06	4.93e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3CA—melanoma	4.84e-06	4.81e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3CA—melanoma	4.57e-06	4.53e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—AKT1—melanoma	4.05e-06	4.03e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—AKT1—melanoma	3.96e-06	3.93e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—AKT1—melanoma	3.73e-06	3.7e-05	CbGpPWpGaD
